JAK2 L884P Mutation Confers Resistance To The Type II JAK2 Inhibitor NVP-BBT594 When Co-Occurring With JAK2 R683G But Not JAK2 V617F

被引：0
|
作者：
Kopp, Nadja
Van der Zwet, Jordy C.
Layer, Jacob
Weigert, Oliver
Vangrevelinghe, Eric
Yoda, Akinori
Radimerski, Thomas
Weinstock, David
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1429.1429
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1429
引用
收藏
页数：2
相关论文
共 50 条
  • [1] JAK2, the JAK2 V617F mutant and cytokine receptors
    Staerk, J.
    Kallin, A.
    Royer, Y.
    Diaconu, C. C.
    Dusa, A.
    Demoulin, J.-B.
    Vainchenker, W.
    Constantinescu, S. N.
    PATHOLOGIE BIOLOGIE, 2007, 55 (02): : 88 - 91
  • [2] A regulating role of the JAK2 FERM domain in hyperactivation of JAK2(V617F)
    Zhao, Lequn
    Ma, Yue
    Seemann, Joachim
    Huang, Lily Jun-Shen
    BIOCHEMICAL JOURNAL, 2010, 426 : 91 - 98
  • [3] Neutrophilia and the JAK2 V617F Mutation
    Langabeer, Stephen E.
    Haslam, Karl
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 437 - 438
  • [4] Splenomegaly and the JAK2 V617F mutation
    Langabeer, Stephen E.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 37 : E45 - E46
  • [5] JAK2 Overexpression Is a Prognostic Indicator for Worse Outcome in Nasopharyngeal Carcinoma and Is Independent of JAK2 Exon 12 and JAK2 V617F Mutation
    Liang, Peir-In
    Li, Chien-Feng
    LABORATORY INVESTIGATION, 2016, 96 : 325A - 325A
  • [6] JAK2 Overexpression Is a Prognostic Indicator for Worse Outcome in Nasopharyngeal Carcinoma and Is Independent of JAK2 Exon 12 and JAK2 V617F Mutation
    Liang, Peir-In
    Li, Chien-Feng
    MODERN PATHOLOGY, 2016, 29 : 325A - 325A
  • [7] AT9283, a potent inhibitor of JAK2, is active in JAK2 V617F myeloproliferative disease models
    Squires, Matthew S.
    Cuny, Jayne E.
    Dawson, Mark A.
    Scott, Mike A.
    Barber, Kelly
    Reule, Matthias
    Smyth, Tomoko
    Wallis, Nicola
    Yule, Murray
    Thompson, Neil T.
    Lyons, John F.
    Green, Anthony K.
    BLOOD, 2007, 110 (11) : 1035A - 1035A
  • [8] JAK2 (V617F) mutation in healthy individuals
    Passamonti, Francesco
    Rumi, Elisa
    Pietra, Daniela
    Lazzarino, Mario
    Cazzola, Mario
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (04) : 678 - 679
  • [9] Aquagenic pruritus and the JAK2 V617F mutation
    Langabeer, S. E.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2019, 44 (03) : E33 - E33
  • [10] JAK2 V617F mutation and the myeloproliferative disorders
    Vainchenker, William
    Casadevall, Nicole
    HEMATOLOGIE, 2006, 12 (01): : 3 - 7
12345